EFTA02278035
EFTA02278036 DataSet-11
EFTA02278039

EFTA02278036.pdf

DataSet-11 3 pages 415 words document
P17 V16 P19 P21 V15
Open PDF directly ↗ View extracted text
👁 1 💬 0
📄 Extracted Text (415 words)
To: Lesley Groff( From: Richard Kahn Sent subsa Thu. PM Re: i will mention to jee when we speak next thanks am. Richard Kahn HBRK Associates Inc. 575 Lexington Avenue 4th Floor New York NY 10022 tel fax cell On Jan 17, 2019, at 12:19 PM, Lesley Groff ‹ > wrote: requested I forward you the below `catch up' email. Christina Galbraith Director of Genetic Therapies Bioilebe LLC <1506365439123blobjpg> Fo From: To: jeevacationAomail.com <jeevacabonOornail.com>; Sent: Wednesday, January 16, 2019, 11:22:06 PM EST EFTA_R1_01093559 EFTA02278036 Subject: Catching Up Dear Jeffrey I hope you've been well. I wanted to update you on what I've been up to for the last two years. I was also hoping to talk with you to see if I might use the foundation's Lexington office conference room from time to time for my work and what I could provide in exchange for that. I am &ling Rich because I'm not sure if you still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapies are genetic vectors, and have to show remarkable results at the mouse level and beyond. Regenerative medicine is a rapidly evolving field, and one that forces the medical industry to shift their focus from addressing symptoms of disease to fundamental evolutionary shortfalls. So far, I placed a genetic vector at the National Institute of Medicine in France (that reversed glaucoma in mice using the neuroglobin gene) under formal licence review with a publicly traded pharma group here in the US. And I am collaborating with a lab at the University of Pittsburgh that has reversed cirrhosis/ end stage liver disease in rats using the master transcription gene in hepatocytes. The concept of the latter gene vector is really intriguing in that a master transcription gene completely restored liver function by rebalancing genetic expression and thus proteostasis. While I don't really need an office at this point, I do need access to a conference room from time to time and it would be hugely helpful if I could access the foundation's. If there was some work that I could do for the foundation in exchange, I would be delighted to do that. It would be wonderful to catch up with you as well. all the best, EFTA_R1_01093560 EFTA02278037 <1506365439123blobjpg> <I 506365439123blobjpg><1506365439123blobjpg> EFTA_R1_01093561 EFTA02278038
ℹ️ Document Details
SHA-256
25778fbca01431f490f91efa4bcfddc7da2a08a448af6027a8f3b1b2a96db276
Bates Number
EFTA02278036
Dataset
DataSet-11
Document Type
document
Pages
3

Comments 0

Loading comments…
Link copied!